Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 2/2016

01-02-2016 | Original Paper

High Prevalence of Assisted Injection Among Street-Involved Youth in a Canadian Setting

Authors: Tessa Cheng, Thomas Kerr, Will Small, Huiru Dong, Julio Montaner, Evan Wood, Kora DeBeck

Published in: AIDS and Behavior | Issue 2/2016

Login to get access

Abstract

Many people who inject illicit drugs receive manual assistance when injecting, and this practice has been linked to increased risk of HIV infection and other harms. Little is known, however, about this practice among youth. This study uses a multivariate generalized estimating equation to identify factors associated with receiving assistance with injecting among a cohort of street-involved youth aged 14–26 in Vancouver, Canada. A total of 253 participants reported injecting drugs during the study period, and 49 % (n = 125) of these youth reported receiving assistance with injecting in the past 6 months. In multivariate analysis, younger age, female gender, binge drug use, heroin injecting, cocaine injecting, crystal methamphetamine injecting, and syringe sharing were positively and independently associated with assisted injection (all p < 0.05). These findings underscore the need for expanding substance abuse treatment alongside HIV prevention and health promotion interventions to empower youth to enact safer injection practices.
Literature
1.
Fairbairn N, Small W, Van Borek N, Wood E, Kerr T. Social structural factors that shape assisted injecting practices among injection drug users in Vancouver, Canada: a qualitative study. Harm Reduct J. 2010;7:20.PubMedCentralCrossRefPubMed
2.
O’Connell JM, Kerr T, Li K, Tyndall MW, Hogg RS, Montaner JS, et al. Requiring help injecting independently predicts incident HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2005;40(1):83–8.CrossRefPubMed
3.
Miller CL, Johnston C, Spittal PM, Li K, Laliberte N, Montaner JS, et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002;36(3):737–42.CrossRefPubMed
4.
Fairbairn N, Wood E, Small W, Stoltz JA, Li K, Kerr T. Risk profile of individuals who provide assistance with illicit drug injections. Drug Alcohol Depend. 2006;82(1):41–6.CrossRefPubMed
5.
Wood E, Spittal PM, Kerr T, Small W, Tyndall MW, O’Shaughnessy MV, et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health Rev/Can de Sante Publique. 2003;94((5):355–9.
6.
McNeil R, Small W, Lampkin H, Shannon K, Kerr T. “People knew they could come here to get help”: an ethnographic study of assisted injection practices at a peer-run ‘unsanctioned’ supervised drug consumption room in a Canadian setting. AIDS Behav. 2014;18(3):473–85.PubMedCentralCrossRefPubMed
7.
Rhodes T. The ‘risk environment’: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85–94.CrossRef
8.
Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003;80(1):137–46.PubMedCentralCrossRefPubMed
9.
Bourgois P, Prince B, Moss A. The everyday violence of hepatitis C among young women who inject drugs in San Francisco. Hum Organ. 2004;63(3):253–64.PubMedCentralCrossRefPubMed
10.
Small W, Shoveller J, Moore D, Tyndall M, Wood E, Kerr T. Injection drug users’ access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture. Qual Health Res. 2011;21(6):743–56.CrossRefPubMed
11.
Kerr T, Wood E, Small D, Palepu A, Tyndall MW. Potential use of safer injecting facilities among injection drug users in Vancouver’s Downtown Eastside. Can Med Assoc J. 2003;169(8):759–63.
12.
13.
Lloyd-Smith E, Rachlis BS, Tobin D, Stone D, Li K, Small W, et al. Assisted injection in outdoor venues: an observational study of risks and implications for service delivery and harm reduction programming. Harm Reduct J. 2010;7:6.PubMedCentralCrossRefPubMed
14.
Marshall BD, Kerr T, Qi J, Montaner JS, Wood E. Public injecting and HIV risk behaviour among street-involved youth. Drug Alcohol Depend. 2010;110(3):254–8.PubMedCentralCrossRefPubMed
15.
Marshall B, Kerr T, Shoveller J, Montaner J, Wood E. Structural factors associated with an increased risk of HIV and sexually transmitted infection transmission among street-involved youth. BMC Public Health. 2009;9(1):7.PubMedCentralCrossRefPubMed
16.
DeMatteo D, Major C, Block B, Coates R, Fearon M, Goldberg E, et al. Toronto street youth and HIV/AIDS: prevalence, demographics, and risks. J Adolesc Health. 1999;25(5):358–66.CrossRefPubMed
17.
Marshall BDL, Kerr T, Shoveller JA, Patterson TL, Buxton JA, Wood E. Homelessness and unstable housing associated with an increased risk of HIV and STI transmission among street-involved youth. Health Place. 2009;15(3):783–90.CrossRef
18.
Wood E, Stoltz JA, Montaner JS, Kerr T. Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study. Harm Reduct J. 2006;3:18.PubMedCentralCrossRefPubMed
19.
Marshall BD. The contextual determinants of sexually transmissible infections among street-involved youth in North America. Cult health Sex. 2008;10(8):787–99.CrossRef
20.
Roy E, Haley N, Leclerc P, Sochanski B, Boudreau JF, Boivin JF. Mortality in a cohort of street youth in Montreal. JAMA. 2004;292(5):569–74.CrossRefPubMed
21.
Roy É, Robert M, Fournier L, Vaillancourt É, Vandermeerschen J, Boivin J-F. Residential trajectories of street youth—the Montréal cohort study. J Urban Health. 2014;91(5):1019–31.PubMedCentralCrossRefPubMed
22.
Uhlmann S, DeBeck K, Simo A, Kerr T, Montaner JS, Wood E. Health and social harms associated with crystal methamphetamine use among street-involved youth in a Canadian setting. Am J Addict/Am Acad Psychiatr Alcohol Addict. 2014;23(4):393–8.CrossRef
23.
Hadland SE, Marshall BD, Kerr T, Zhang R, Montaner JS, Wood E. A comparison of drug use and risk behavior profiles among younger and older street youth. Subst Use Misuse. 2011;46(12):1486–94.PubMedCentralCrossRefPubMed
24.
Ballinger GA. Using generalized estimating equations for longitudinal data analysis. Organ Res Methods. 2004;7(2):127–50.CrossRef
25.
Hanley JA, Negassa A, Edwardes MD, Forrester JE. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol. 2003;157(4):364–75.CrossRefPubMed
26.
Pan W. Akaike’s information criterion in generalized estimating equations. Biometrics. 2001;57(1):120–5.CrossRefPubMed
27.
Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 1999;94(5):675–83 (Abingdon, England).CrossRefPubMed
28.
Fairbairn N, Small W, Shannon K, Wood E, Kerr T. Seeking refuge from violence in street-based drug scenes: women’s experiences in North America’s first supervised injection facility. Soc Sci Med. 2008;67(5):817–23.CrossRefPubMed
29.
Fast D, Small W, Wood E, Kerr T. Coming ‘down here’: young people’s reflections on becoming entrenched in a local drug scene. Soc Sci Med. 2009;69(8):1204–10.PubMedCentralCrossRefPubMed
30.
Werb D, Kerr T, Buxton J, Shoveller J, Richardson C, Montaner J, et al. Crystal methamphetamine and initiation of injection drug use among street-involved youth in a Canadian setting. Can Med Assoc J. 2013;185(18):1569–75.CrossRef
31.
Small W, Fast D, Krusi A, Wood E, Kerr T. Social influences upon injection initiation among street-involved youth in Vancouver, Canada: a qualitative study. Subst Abuse Treat Prev Policy. 2009;4:8.PubMedCentralCrossRefPubMed
32.
Kerr T, Oleson M, Tyndall MW, Montaner J, Wood E. A description of a peer-run supervised injection site for injection drug users. J Urban Health. 2005;82(2):267–75.PubMedCentralCrossRefPubMed
33.
Small W, Wood E, Tobin D, Rikley J, Lapushinsky D, Kerr T. The injection support team: a peer-driven program to address unsafe injecting in a Canadian setting. Subst Use Misuse. 2012;47(5):491–501.CrossRefPubMed
34.
Hayashi K, Wood E, Wiebe L, Qi J, Kerr T. An external evaluation of a peer-run outreach-based syringe exchange in Vancouver Canada. Int J Drug Policy. 2010;21(5):418–21.PubMedCentralCrossRefPubMed
35.
Ritter A, Ritter A, Cameron J, Ritter A, Cameron J. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug Alcohol Rev. 2006;25(6):611–24.CrossRefPubMed
36.
Buxton JA, Dove NA. The burden and management of crystal meth use. Can Med Assoc J. 2008;178(12):1537–9.CrossRef
37.
Miller CL, Kerr T, Frankish JC, Spittal PM, Li K, Schechter MT, et al. Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies. Subst Use Misuse. 2006;41(2):199–210.CrossRefPubMed
38.
Miller CL, Strathdee SA, Kerr T, Li K, Wood E. Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. J Adolesc Health. 2006;38(4):462–4.CrossRefPubMed
39.
Ochnio JJ, Patrick D, Ho M, Talling DN, Dobson SR. Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs. Can Med Assoc J. 2001;165(3):293–7.
40.
Podsakoff PM, MacKenzie SB, Lee J-Y, Podsakoff NP. Common method biases in behavioral research: a critical review of the literature and recommended remedies. J Appl Psychol. 2003;88(5):879.CrossRefPubMed
41.
Brener ND, Collins JL, Kann L, Warren CW, Williams BI. Reliability of the youth risk behavior survey questionnaire. Am J Epidemiol. 1995;141(6):575–80.PubMed
42.
Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253–63.CrossRefPubMed
43.
Rosenbaum JE. Truth or consequences: the intertemporal consistency of adolescent self-report on the youth risk behavior survey. Am J Epidemiol. 2009;169(11):1388–97.PubMedCentralCrossRefPubMed
44.
Small W, Krusi A, Wood E, Montaner J, Kerr T. Street-level policing in the Downtown Eastside of Vancouver, Canada, during the 2010 Winter Olympics. Int J Drug Policy. 2012;23(2):128–33.CrossRefPubMed
45.
Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Arch Intern Med. 2001;161(1):85–91.CrossRefPubMed
Metadata
Title
High Prevalence of Assisted Injection Among Street-Involved Youth in a Canadian Setting
Authors
Tessa Cheng
Thomas Kerr
Will Small
Huiru Dong
Julio Montaner
Evan Wood
Kora DeBeck
Publication date
01-02-2016
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2016
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-015-1101-3

Other articles of this Issue 2/2016

AIDS and Behavior 2/2016 Go to the issue

Brief Report

Using Capture-Recapture Methods to Estimate the Population of People Who Inject Drugs in Washington, DC

Original Paper

Exploring Coping and Social Support with Gender and Education Among People Living with HIV in China

Original Paper

High HIV Prevalence and Associated Risk Factors Among Female Sexual Partners of Male Injection Drug Users (MWID) in Ho Chi Minh City, Vietnam

Original Paper

“Outness” as a Moderator of the Association Between Syndemic Conditions and HIV Risk-Taking Behavior Among Men Who Have Sex with Men in Tijuana, Mexico

Substantive Review

A Systematic Review of HIV Risk Behaviors and Trauma Among Forced and Unforced Migrant Populations from Low and Middle-Income Countries: State of the Literature and Future Directions

Original Paper

Improvements in Depression and Changes in Fatigue: Results from the SLAM DUNC Depression Treatment Trial
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits